Answers are grounded in this paper and cite their sources.
The fourth most frequent cancer in the world is Gastric cancer and also the second leading cause of cancer-related fatalities. Despite substantial research into new diagnostic and therapeutic agents, patients with advanced stomach cancer have a low quality of life and a dismal prognosis, and treatment is mostly cytotoxic chemotherapy. A deeper knowledge of the underlying molecular pathologies, as well as their application toward the development of innovative therapeutic strategies, is essential for improving the quality of life and survival of gastric cancer patients
No takes yet. Share an insight, caveat, or question.
Tripathi et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: